(All fields required)
Please enter a valid email.
Please enter your name.
A program within the Infectious Diseases Division at Cincinnati Children’s, the Gamble Program for Clinical Studies is responsible for the management of the clinical trials program. The emphasis of the clinical trials is on vaccines and antivirals. The studies include all ages, from infants to the elderly.
The Gamble Program for Clinical Studies is focused on the diagnosis, prevention and treatment of diseases caused by viruses such as:
In 1994 and again in 2001 and 2007, the Gamble Program was designated as one of seven Vaccine and Treatment Evaluation Units (VTEUs) of the National Institute of Allergy and Infectious Diseases of the NIH. These seven-year contracts are dedicated to finding improved vaccines and better treatments for infectious diseases. The Gamble Program’s scope of activities include:
Cincinnati Children’s has received a seven-year, $23.7 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), as one of eight Vaccine and Treatment Evaluation Units (VTEUs) in the United States.
The funding is among the largest contracts or grants that Cincinnati Children’s has received.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center